FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020175863> ?p ?o ?g. }

• W2020175863 endingPage "592" @default.
• W2020175863 startingPage "585" @default.
• W2020175863 abstract "The authors investigated the effects of rosuvastatin, beyond its lipid-lowering activity, on several nonlipid metabolic variables, along with its safety and tolerability, in patients treated for primary hyperlipidemia. Patients (n=55) with primary hyperlipidemia were open-label assigned to the recommended starting dose of rosuvastatin 10 mg/day, and serum metabolic variables were measured at baseline and after 8 and 20 weeks. Treatment with rosuvastatin produced significant reductions in total cholesterol, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B, nonhigh-density lipoprotein cholesterol (non HDL-C), and triglyceride concentrations, whereas HDL-C, apolipoprotein A-I, and lipoprotein(a) levels did not change significantly from baseline. The LDL-C treatment target was achieved in 71% of patients. No significant variations in renal function parameters (serum creatinine and creatinine clearance), insulin resistance estimates, and serum concentrations of uric acid, total homocysteine, vitamin B12, and folic acid were observed during the period of treatment. High-sensitivity C-reactive protein levels were significantly lowered by rosuvastatin therapy (median values, 3.1 vs 2.0 vs 1.9 mg/L, at 0, 8, and 20 weeks, respectively; p<0.0001). In conclusion, rosuvastatin at 10 mg/day is a highly effective, safe, and well-tolerated monotherapy option for patients with primary hyperlipidemia, with a favorable antiinflammatory potential and nondeteriorating effects on renal function." @default.
• W2020175863 created "2016-06-24" @default.
• W2020175863 creator A5011142806 @default.
• W2020175863 creator A5011338992 @default.
• W2020175863 creator A5032218366 @default.
• W2020175863 creator A5056134447 @default.
• W2020175863 creator A5064886621 @default.
• W2020175863 creator A5074905198 @default.
• W2020175863 creator A5081120507 @default.
• W2020175863 creator A5082739145 @default.
• W2020175863 date "2005-09-01" @default.
• W2020175863 modified "2023-09-27" @default.
• W2020175863 title "Starting with Rosuvastatin in Primary Hyperlipidemia—" @default.
• W2020175863 cites W1502524639 @default.
• W2020175863 cites W1550111394 @default.
• W2020175863 cites W1966088505 @default.
• W2020175863 cites W1975357252 @default.
• W2020175863 cites W1977868067 @default.
• W2020175863 cites W1979556028 @default.
• W2020175863 cites W1981155050 @default.
• W2020175863 cites W1986574097 @default.
• W2020175863 cites W1995364818 @default.
• W2020175863 cites W2002019607 @default.
• W2020175863 cites W2003382978 @default.
• W2020175863 cites W2019266035 @default.
• W2020175863 cites W2038261200 @default.
• W2020175863 cites W2053358292 @default.
• W2020175863 cites W2061489988 @default.
• W2020175863 cites W2061762222 @default.
• W2020175863 cites W2063543638 @default.
• W2020175863 cites W2066898102 @default.
• W2020175863 cites W2082279418 @default.
• W2020175863 cites W2087219735 @default.
• W2020175863 cites W2088531744 @default.
• W2020175863 cites W2090117778 @default.
• W2020175863 cites W2090170448 @default.
• W2020175863 cites W2092950390 @default.
• W2020175863 cites W2098894835 @default.
• W2020175863 cites W2102899779 @default.
• W2020175863 cites W2113275507 @default.
• W2020175863 cites W2113670840 @default.
• W2020175863 cites W2115375433 @default.
• W2020175863 cites W2118154631 @default.
• W2020175863 cites W2135648839 @default.
• W2020175863 cites W2136610077 @default.
• W2020175863 cites W2151628775 @default.
• W2020175863 cites W2152211449 @default.
• W2020175863 cites W2154704322 @default.
• W2020175863 cites W2160234571 @default.
• W2020175863 cites W2231069932 @default.
• W2020175863 cites W2315618879 @default.
• W2020175863 cites W2316376271 @default.
• W2020175863 cites W4238251256 @default.
• W2020175863 doi "https://doi.org/10.1177/000331970505600510" @default.
• W2020175863 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16193198" @default.
• W2020175863 hasPublicationYear "2005" @default.
• W2020175863 type Work @default.
• W2020175863 sameAs 2020175863 @default.
• W2020175863 citedByCount "16" @default.
• W2020175863 countsByYear W20201758632012 @default.
• W2020175863 countsByYear W20201758632013 @default.
• W2020175863 countsByYear W20201758632014 @default.
• W2020175863 countsByYear W20201758632017 @default.
• W2020175863 countsByYear W20201758632020 @default.
• W2020175863 crossrefType "journal-article" @default.
• W2020175863 hasAuthorship W2020175863A5011142806 @default.
• W2020175863 hasAuthorship W2020175863A5011338992 @default.
• W2020175863 hasAuthorship W2020175863A5032218366 @default.
• W2020175863 hasAuthorship W2020175863A5056134447 @default.
• W2020175863 hasAuthorship W2020175863A5064886621 @default.
• W2020175863 hasAuthorship W2020175863A5074905198 @default.
• W2020175863 hasAuthorship W2020175863A5081120507 @default.
• W2020175863 hasAuthorship W2020175863A5082739145 @default.
• W2020175863 hasConcept C126322002 @default.
• W2020175863 hasConcept C134018914 @default.
• W2020175863 hasConcept C159641895 @default.
• W2020175863 hasConcept C197934379 @default.
• W2020175863 hasConcept C2778163477 @default.
• W2020175863 hasConcept C2778375690 @default.
• W2020175863 hasConcept C2779091943 @default.
• W2020175863 hasConcept C2779881121 @default.
• W2020175863 hasConcept C2780306776 @default.
• W2020175863 hasConcept C2780499067 @default.
• W2020175863 hasConcept C555293320 @default.
• W2020175863 hasConcept C62746215 @default.
• W2020175863 hasConcept C71924100 @default.
• W2020175863 hasConceptScore W2020175863C126322002 @default.
• W2020175863 hasConceptScore W2020175863C134018914 @default.
• W2020175863 hasConceptScore W2020175863C159641895 @default.
• W2020175863 hasConceptScore W2020175863C197934379 @default.
• W2020175863 hasConceptScore W2020175863C2778163477 @default.
• W2020175863 hasConceptScore W2020175863C2778375690 @default.
• W2020175863 hasConceptScore W2020175863C2779091943 @default.
• W2020175863 hasConceptScore W2020175863C2779881121 @default.
• W2020175863 hasConceptScore W2020175863C2780306776 @default.
• W2020175863 hasConceptScore W2020175863C2780499067 @default.
• W2020175863 hasConceptScore W2020175863C555293320 @default.
• W2020175863 hasConceptScore W2020175863C62746215 @default.

• next